GEHC is a new spinoff from General Electric. It has great success thus far with good earnings reports and no dependency on debt and interest rates. It has been on an uptrend since the November earnings. At present it is correcting. I will play this going short on shares while hedging with a long term call options. I am in GE calls out into 2026. A long term...
IRTC on the weekly chart shows a symmetrical triangle with compression of price into the apex confluent with the 5 year anchored mean VWAP. I am very familiar with the product line including often lifesaving technology such as AEDs. The company has had weak earnings reports but price has managed to so from undervalued to fair value. I will add to my...
ZBH is a big global medical device company. It is old school. Aluminum titanium polymers, plates screws wires. Hollywood stars are familiar as it makes the devices for leg lengthening surgery. ( shortening is easy, lengthening not so much) I am familiar because in the past I have served as a consultant for this company. It business is mainly orthopedic elective...
Stryker Corp. (SYK) presently trading above key resistance, able to absorb weekly selling pressures. A weekly settlement above this resistance zone would place (SYK) into a buy signal where gains of 20% would be expected over the following 3 - 5 months. Inversely, failing to close above this resistance level on a weekly basis, or closing back below this...
RS ratio and OBV already broke out and are near highs. I added today for the CMT Investment Challenge in anticipation of the breakout above $280. If it breaks that resistence level I'll buy for my personal portfolio.
Could wait for confirmation, but I prefer to buy at support (bottom of pennant, so I can set a tight stop) and sell if there's major resistance at top of pennant, but I'm expecting a breakout to upside.
$SYK is breaking out the fibonacci 0.618. It is also important to close above the last high $190.72. RSI is still challenging with last high. needs more volume.
We keep seeing Clinical Stage Companies that are publicly traded, with new FDA Approvals, and the stocks are blasting off. Many of those are trading over $100 with no revenue, profits or earnings. Here Merck is, sitting under $100, beating earnings, with record revenue and profit, and paying an almost 3.00% dividend....It is simply outrageous. Wall Street...
SYK about to drop below the neckline. weekly divergence and bearish candle confirms the downside. TP 140, 120 P/L ~17% and 27%
SYK- Falling wedge Second occurrence this year, first broke out pretty early. Second one is following the pattern much closer. Take a look and let me know.
SYK- Wedge pattern is occurring for a second time in this stock this year. Previous one broke out a little early, however this on is following the pattern much closer. Made some brief notes on the expanded chart, take a look and let me know what you all think.
With Intuitive, Stryker all up at all time highs i'm hunting for medical robotics companies to acquire. Smith & Nephew looking for a move below 29 to get long seekingalpha.com